Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TECHNICAL CHEMICALS TO MARKET EIGHT HEALTH TEST DIAGNOSTICS

This article was originally published in The Tan Sheet

Executive Summary

TECHNICAL CHEMICALS TO MARKET EIGHT HEALTH TEST DIAGNOSTICS -- including pregnancy and fecal occult blood tests -- approximately eight months after its initial public offering is "successfully consummated," the firm predicted in a preliminary prospectus for the IPO. Pompano Beach, Fla.-based Technical Chemicals and Products, Inc. specifically mentioned three versions of its pregnancy test, which have all received FDA clearance for over- the-counter use. Two of the tests come in a test strip format on which several drops of sample are applied, and the other test is a "midstream wand" that is dipped in urine.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel